ADMA: ADMA Biologics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

ADMA Biologics, Inc.

NASDAQ:ADMA

SummaryFactSheetFinancial
Price
$8.17
Loss Chance
43.1%
5.50JITTA SCORE
52.11%Under Jitta Line
Jitta Ranking
Biotechnology
10 / 283
Health Care
52 / 718
United States
?
628 / 4,226
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.23
39.10%
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.23
39.10%
Compugen Ltd.
NASDAQ:CGEN
4.58
$2.90
54.25%
Exelixis
NASDAQ:EXEL
6.93
$48.16
34.82%
Halozyme Therapeutics
NASDAQ:HALO
6.45
$64.12
57.30%
Jitta Factors
Growth Opportunity (87)
Recent Business Performance (84)
Financial Strength (65)
Return to Shareholders (30)
Competitive Advantage (70)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2022
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.50
52.11%
2.20
144.61%
3.06
136.28%
Biotechnology
5.68
39.10%
5.68
39.10%
4.58
54.25%
COMPANY DESCRIPTION
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
www.admabiologics.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.